Predict closed the first half of 2026 with sales revenue of €4.01 million, up 67.3%, and positive EBITDA of €0.40 million. The net result was close to break-even.
Key figures
- Sales revenue: €4.01 million, +67.3%
- EBITDA: €0.40 million, from -€0.27 million
- EBITDA margin: 9.8%, from -11.4%
- Net result: -€521, from -€0.44 million
- Net cash: €0.95 million
- Adjusted net cash: €1.15 million
The Imaging division generated €3.15 million in revenue, up 76%, while People Support reached €0.66 million, an increase of 30.5%. Digital Healthcare contributed €0.20 million and more than doubled compared with the year-earlier period.
The return to positive EBITDA and the near break-even net result mark a clear operating improvement from the first half of 2025. Net cash decreased from €1.84 million at the end of 2025 to €0.95 million at 30 June 2026, while the adjusted measure stood at €1.15 million.
The company
Predict is a Bari-based medtech company active in diagnostic imaging, breath-analysis systems, robotics and digital healthcare solutions. It is listed on Euronext Growth Milan under ticker PRE.
Primary source: Predict, consolidated results at 30 June 2026.